massachusetts institute of technology today's spotlight about
Close
Spotlight image Spotlight image
The iconic MIT home page Spotlight features a daily-changing image and design that focuses on advances in research, technology and education taking place at the Institute. Though some Spotlights do run multiple days - for example Friday's spot usually runs through the weekend, we work very hard to maintain the daily-changing tradition. We've combed our servers and have compiled a digital archive of the Institute home page through the years - well over 2000 images. Enjoy!
Close
Campus crossroads Today’s spotlight features a still from the Muddy Charles video by Melanie Gonick.

Since 1968, the Muddy Charles Pub (opens in new window) has been a spot for the MIT community to relax, socialize, and share ideas. It’s also become a networking hub for researchers, entrepreneurs, and alumni (opens in new window) in the public sector and in industry.

Watch video.

Visit MIT News.
The MIT home page Spotlight showcases the research, technology and education advances taking place at the Institute every day.

What makes it as a Spotlight image is an editorial decision by the MIT News Office based on factors that include timeliness, promotion of MIT's mission, the balance of interest to both internal and external audiences, and appropriateness.

We do welcome ideas and submissions for spotlights from community members, but please note we are not able to accommodate all requests. We are unable to run event previews or promotions as spotlights; for those looking to promote an event, we are happy to include your listing as an event headline on the homepage (when space is available). For more information, e-mail the spotlight team.

New lung cancer target

New lung cancer target

Today's Spotlight features an image, courtesy of National Cancer Institute and Huntsman Cancer Institute at the Univ. of Utah, of lung cancer, in purple, that is driven by the KRAS oncogene.

Mutations in the KEAP1 gene could point the way to treating an aggressive form of lung cancer that is driven by "undruggable" mutations in the KRAS gene, according to a new study by MIT researchers.

Read the story at MIT News.